Trial intelligence / Profile preview

CAMERA: Carvedilol vs Metoprolol Respiratory Assessment

NCT00384566Phase 4Withdrawn

Sponsor
Alfred Health
Start
Jun 2005
Primary completion
Apr 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of carvedilol in heart failure (HF) (2 arms), sponsored by Alfred Health. Primary endpoints: Respiratory function, NYHA class and 4 more. Planned start Jun 2005; status: withdrawn.

02

Drugs

carvedilol
03

Conditions

heart failure (HF)

Beyond the preview

Go deeper on NCT00384566.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00384566.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call